Shanghai Pharma Plans San Diego Office for US/EU M&A

China ’s Shanghai Pharma wants to expand its business through M&A, with an eye to overseas transaction, according to the South China Morning Post . Shanghai Pharma is a familiar M&A participant. Recently, however, its thinking has evolved: it is planning to open an office in San Diego sometime in 2018 to spearhead the initiative, and it is thinking partnerships rather than takeovers, partly because of pressure from China and US regulators. More details.... Stock Symbols: (SHA: 601607; HK: 2607) Share this with colleagues: // //